Literature DB >> 3402061

Analytical performance of three commercially available nephelometers compared for quantifying proteins in serum and cerebrospinal fluid.

H J Salden1, B M Bas, I T Hermans, P C Janson.   

Abstract

We investigated the analytical performance and imprecision of three commercially available nephelometers for the quantification of various proteins in pooled serum and cerebrospinal fluid. Albumin, transferrin, IgG, IgA, and IgM in serum were determined nephelometrically (BNA, Behring; Array, Beckman) and turbidimetrically (Cobas Bio, Hoffmann-La Roche). All these proteins in cerebrospinal fluid except transferrin were determined nephelometrically with all three systems. CVs and lower limits of detection were compared for all instruments, and stability of calibration curves was evaluated.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3402061

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


  9 in total

1.  Month-related variability in immunological test results; implications for immunological follow-up studies.

Authors:  Y van Rood; E Goulmy; E Blokland; J Pool; J van Rood; H van Houwelingen
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Development and validation of 14 human serum protein assays on the Roche cobas® c 501.

Authors:  Thomas B Ledue; Marilyn F Collins
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Carmine Tamborino; Silva Seraceni; Maria Rosaria Tola; Enrico Granieri; Carlo Contini
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

4.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

5.  Extreme Diversity of IgGs Against Histones, DNA, and Myelin Basic Protein in the Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis.

Authors:  Irina A Kostrikina; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  Biomolecules       Date:  2020-04-18

6.  Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.

Authors:  Massimiliano Castellazzi; Andrea Morotti; Carmine Tamborino; Francesca Alessi; Silvy Pilotto; Eleonora Baldi; Luisa M Caniatti; Alessandro Trentini; Ilaria Casetta; Enrico Granieri; Maura Pugliatti; Enrico Fainardi; Tiziana Bellini
Journal:  Fluids Barriers CNS       Date:  2020-02-05

7.  Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients.

Authors:  Massimiliano Castellazzi; Caterina Ferri; Sarah Alfiero; Ilenia Lombardo; Michele Laudisi; Ginevra Tecilla; Michela Boni; Stefano Pizzicotti; Enrico Fainardi; Tiziana Bellini; Maura Pugliatti
Journal:  Diagnostics (Basel)       Date:  2021-05-16

8.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

9.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.